Geode Capital Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Geode Capital Management’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-198,099	Closed	-$93	–	4118
2016 Q1	$93	Hold	198,099	–	–	﹤0.01%	3850
2015 Q4	$135K	Hold	198,099	–	–	﹤0.01%	3808
2015 Q3	$192K	Buy	198,099 +15,521	+9%	+$19.1K	﹤0.01%	3694
2015 Q2	$219K	Hold	182,578	–	–	﹤0.01%	3553
2015 Q1	$193K	Hold	182,578	–	–	﹤0.01%	3595
2014 Q4	$199K	Hold	182,578	–	–	﹤0.01%	3585
2014 Q3	$197K	Sell	182,578 -4,310	-2%	-$5.32K	﹤0.01%	3579
2014 Q2	$194K	Sell	186,888 -83,111	-31%	-$79.2K	﹤0.01%	3526
2014 Q1	$278K	Buy	269,999 +61,955	+30%	+$64K	﹤0.01%	3389
2013 Q4	$241K	Buy	208,044 +4,293	+2%	+$6.61K	﹤0.01%	3373
2013 Q3	$342K	Buy	203,751 +8,225	+4%	+$15.2K	﹤0.01%	3114
2013 Q2	$391K	Buy	+195,526	New	+$572K	﹤0.01%	2986

Other funds holding ENZN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

OSAM

O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MCM

Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return

CFA

CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Geode Capital Management's ENZN Position: Q2 2016 in Review

Geode Capital Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 198,099 shares — an estimated $93 sold.

Geode Capital Management first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $391K in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

Geode Capital Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
Geode Capital Management sold 198,099 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $93.
Geode Capital Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
Geode Capital Management's ENZON PHARMACEUTICALS INC position peaked at $391K in Q2 2013.
10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.